Keywords: Infectious Disease, Diffusion/other diffusion imaging techniques, HIV
Motivation: People with HIV and co-morbid severe depression are rarely included in research, despite a critical need for identifying biomarkers for early detection of depression in this group.
Goal(s): We explored whether neuroimaging biomarkers may distinguish between people with HIV experiencing severe or mild depressive symptoms.
Approach: We recruited 11 participants with HIV and severe or mild depressive symptoms, who underwent standard and diffusion-weighted MR spectroscopy and dynamic contrast-enhanced MRI.
Results: We found no significant group differences, but observed correlations of depressive symptom severity with creatine (ρ = 0.66) and NAA (ρ = 0.64) diffusion, though these findings did not survive multiple comparisons correction.
Impact: This is the first study to successfully quantify neurometabolite diffusion in people with HIV and depression. Intracellular diffusion of neurometabolites may be associated with depressive symptom severity in this community, and well-powered studies are needed to resolve this relationship.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords